Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

During the Trading Day
69.73 -0.28 / -0.40%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
69.73 0.00 / 0.00%
 
Volume: 690.3K
Shire buys US eyecare business for $300m
12:41pm / FT.com
AbbVie's Investments Begin Kicking In
Jul 24 / MotleyFool.com
Seattle Genetics (SGEN) Loss Widens in Q2, Ups 2015 View - Analyst Blog
Jul 31 / Zacks.com
AbbVie Tops Earnings, Misses on Revenues, Maintains View - Analyst Blog
Jul 24 / Zacks.com
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press ...
Jul 30 / Zacks.com
AbbVie (ABBV) Tops 2Q Earnings but Misses Revenues - Tale of the Tape
Jul 24 / Zacks.com
Gilead's Hepatitis C Dominance Unchecked By AbbVie
Jul 30 / MotleyFool.com
Will AbbVie (ABBV) Surprise on Earnings Again in Q2? - Analyst Blog
Jul 23 / Zacks.com
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA...
Jul 29 / Zacks.com
Shire still on the hunt for acquisitions
Jul 23 / FT.com
AbbVie (ABBV) Stock Price Target Raised at Deutsche Bank
Jul 29 / TheStreet.com
Celgene Rolling Along (but You Already Knew That)
Jul 23 / MotleyFool.com
Gilead (GILD) Beats on Q2 Earnings, Raises 2015 Outlook - Analyst Blog
Jul 29 / Zacks.com
The Zacks Analyst Blog Highlights: Amgen, Exelixis, Regeneron, Five Prime Therapeutic...
Jul 23 / Zacks.com
Pfizer CEO has 'sufficient courage' to pursue deals
Jul 28 / FT.com
Biotech Stock Roundup: Amgen PCSK9 Inhibitor First to Gain Approval, Exelixis Up on P...
Jul 22 / Zacks.com
The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmace...
Jul 28 / Zacks.com
Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johns...
Jul 22 / Zacks.com
Avoid Gilead Shares for Now
Jul 28 / TheStreet.com
2015bs Top 6 Big Pharma Headlines Thus Far
Jul 22 / MotleyFool.com
Allergan signals appetite for new mega deal after $41bn disposal
Jul 27 / FT.com
Pharma Stock Outlook - July 2015 - Zacks Analyst Interviews
Jul 21 / Zacks.com
4 Stocks to Fight the Virus on World Hepatitis Day - Analyst Blog
Jul 27 / Zacks.com
Pharma Stock Outlook - July 2015 - Industry Outlook
Jul 21 / Zacks.com
Company News for July 27, 2015 - Corporate Summary
Jul 27 / Zacks.com
Acquisitive Celgene shuns usual biotech growth model
Jul 16 / FT.com
3 Signs That the Healthcare Stock Bubble Might Have Just Popped
Jul 27 / MotleyFool.com
Biotech boon as Celgene agrees $7.2bn Receptos deal
Jul 14 / FT.com
Allergan sells generic drugs unit to Teva for $40bn
Jul 27 / FT.com
Johnson & Johnson sales hit by 'biosimilar' competition
Jul 14 / FT.com
Biotech high flyers face gravity test
Jul 27 / FT.com